Study Explores Virus-based Therapy for Neoadjuvant Treatment of BCC
Talimogene laherparepvec (TVEC) may reduce the size of basal cell carcinomas, improving surgical removal and potentially leading to complete regression of the tumour, according to research published in Nature Cancer. TVEC is a genetically modified herpes simplex virus that specifically destroys tumour cells and simultaneously activates the immune system. TVEC has only been approved for […]